A comprehensive view of neurological/cognitive health. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Consumer Wellness Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

Merck KGaA announces acquisition of Chord Therapeutics, a Swiss-based company focused on rare neuroinflammatory diseases; company's research includes focus on antibody-mediated disease

Biogen announces European Commission marketing authorization for orally administered VUMERITY for treatment of relapsing-remitting multiple sclerosis; drug was previously approved in the US, UK and Switzerland

Pfizer and Biohaven Pharmaceutical Holding enter agreement for commercialization of rimegepant outside US; drug is commercialized as Nurtec ODT in the US, used for treatment of migraine attacks

Neurelis commences clinical study to assess use of VALTOCO diazepam nasal spray in children with epilepsy aged two-to-five years needing treatment for seizure clusters; drug currently approved in US for patients aged six years and above

US EPA to end use of chlorpyrifos, a pesticide associated with neurological health problems, on all food products; due to its use on a range of food crops, a significant portion of people in the US reportedly have traces of chlorpyrifos in their bodies

Ask us about our Consumer Wellness market view

Trending Chart

Interactive chart with headline count